Alectinib M4 metabolite D4

Product Information

Product	Alectinib M4 metabolite D4
CAT No.	CS-O-32642
CAS No.	1256585-04-2 (Unlabeled)
Status
Category	Stable Isotopes
Mol. Wt.	460.6 g/mol mol/g
Mol. For.	C₂₈H₂₈D₄N₄O₂
Hazardous	This is not a Hazardous Compound

Product Description

Alectinib M4 metabolite D4 is a chemical compound that is produced as a metabolite of Alectinib, a medication used for the treatment of advanced non-small cell lung cancer. Alectinib M4 metabolite D4 is an active metabolite of Alectinib and has similar pharmacological effects. Alectinib M4 metabolite D4 is a potent inhibitor of the anaplastic lymphoma kinase (ALK) and the c-ros oncogene 1 (ROS1). These proteins are known to promote the growth and spread of cancer cells in the body. By inhibiting these proteins, Alectinib M4 metabolite D4 slows down the growth and spread of cancer cells, thereby helping to manage cancer. Alectinib M4 metabolite D4 is usually administered orally, and its dosage is determined by a healthcare professional based on the patient's medical condition and response to treatment. The medication is available in capsule form, and it is important to follow the prescribed dosage and duration of treatment. Like all medications, Alectinib M4 metabolite D4 has potential side effects. Some of the common side effects include fatigue, nausea, vomiting, diarrhea, and constipation. Patients undergoing treatment with Alectinib M4 metabolite D4 should be monitored closely by a healthcare professional for any adverse effects or allergic reactions. In conclusion, Alectinib M4 metabolite D4 is an important medication used in the management of advanced non-small cell lung cancer. Its potent inhibitory effects on ALK and ROS1 make it a valuable treatment option for patients with this condition.

Additional Information

Packing	Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled	No
Parent API	Alectinib
Therapeutic	Anti-Cancer / Oncology
Canonical Smiles	CCC1=CC2=C(C=C1N3CCC(CC3)NCCO)C(C4=C(C2=O)C5=C(N4)C=C(C=C5)C#N)(C)C
InchIKey	XNKBNGIKXNABDO-UHFFFAOYSA-N
Inchl	InChI=1S/C28H32N4O2/c1-4-18-14-21-22(15-24(18)32-10-7-19(8-11-32)30-9-12-33)28(2,3)27-25(26(21)34)20-6-5-17(16-29)13-23(20)31-27/h5-6,13-15,19,30-31,33H,4,7-12H2,1-3H3
IUPAC	9-ethyl-8-[4-(2-hydroxyethylamino)piperidin-1-yl]-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile
Hazardous	No

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information	Use proper personal protective equipment
Handling	Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control	Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing	Wear appropriate protective clothing to minimize contact with skin.
Skin	Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes	Wear safety glasses and chemical goggles if splashing is possible.
Inhalation	Remove from exposure and move to fresh air immediately.

What we promise?

30-Days Money Back
Complete Documentation
Worldwide Delivery
Product Accuracy

Read about our Packaging

Sample Label

Alectinib M4 metabol...

www.clearsynth.com

CAT : CS-O-32642	BATCH : CSC-WWW0757

MF: C28H28D4N4O2 CAS: 1256585-04-2 (Unlabeled) Date of Anaysis: 22-Aug-2023 Retest Date: 22-Jun-2026	MW: 460.6 g/mol Store at refrigerator (2-8C)	Qty: 60 MG
Only for R & D and Analytical purpose, Not for Human Consumption.